Quarterly ResultJul 28, 2026, 04:08 PM
Tilray Brands Reports Record FY26 Revenue $915M, Adj. EBITDA $61.1M
AI Summary
Tilray Brands, Inc. reported record financial results for fiscal year 2026, with net revenue increasing 11% to $915.5 million and adjusted EBITDA reaching a record $61.1 million. The company highlighted strong growth in international medical cannabis revenue, up 34%, and the strategic expansion of its beverage platform through the BrewDog acquisition. Tilray also strengthened its financial position, ending the year with approximately $235 million in cash and marketable securities and reducing net debt to $0.7 million, while providing positive adjusted EBITDA guidance for fiscal year 2027.
Key Highlights
- Fiscal Year 2026 Net Revenue increased 11% to a record $915.5 million.
- Fiscal Year 2026 Adjusted EBITDA increased to a record $61.1 million.
- International Medical Cannabis Revenue grew 34% for the fiscal year.
- Ended fiscal year 2026 with approximately $235 million in cash, restricted cash, and marketable securities.
- Net Debt reduced to $0.7 million, strengthening the balance sheet.
- Fiscal Year 2027 Adjusted EBITDA guidance set at $68 million to $75 million.
- Acquisition of BrewDog accelerated global beverage platform expansion.
- Adjusted net income for FY26 increased almost 90% to $12.2 million, with adjusted EPS of $0.11.
Price Impact
More from TLRY